Atara Biotherapeutics Inc (ATRA)
10.61
-0.07
(-0.66%)
USD |
NASDAQ |
Nov 21, 16:00
10.60
-0.01
(-0.09%)
After-Hours: 20:00
Atara Biotherapeutics Gross Profit Margin (Quarterly): 81.08% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 81.08% |
| June 30, 2024 | 83.84% |
| March 31, 2024 | 92.74% |
| December 31, 2023 | 25.68% |
| Date | Value |
|---|---|
| September 30, 2023 | -22.31% |
| June 30, 2023 | -202.5% |
| March 31, 2023 | 82.38% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-202.5%
Minimum
Jun 2023
92.74%
Maximum
Mar 2024
20.13%
Average
81.08%
Median
Sep 2024
Gross Profit Margin (Quarterly) Benchmarks
| Azenta Inc | 40.82% |
| Perspective Therapeutics Inc | -- |
| Corvus Pharmaceuticals Inc | -- |
| Clearside Biomedical Inc | -- |
| Quanterix Corp | 58.03% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -85.41% |
| Profit Margin (Quarterly) | -54.51% |
| Operating Margin (Quarterly) | -54.14% |
| Return on Net Operating Assets | -160.3% |